For this reason, the aim of revising all studies evaluating the frequency of mutations of BRAF, NRAS, and KIT genes are to determine the correlation of the clinical-pathological characteristics of melanomas, and the demographic characteristics of the analysed populations. Here, NRAS is linked to melanoma.